**
In a significant safety alert, the U.S. Food and Drug Administration (FDA) has announced the voluntary recall of several lots of Gas-X Extra Strength Softgels due to potential contamination. The manufacturing company Haleon has flagged the issue, which affects consumers nationwide, citing risks associated with a diluted coolant that may have inadvertently leaked during the packaging process.
Details of the Recall
The recalled Gas-X Extra Strength Softgels, designed to alleviate discomfort from gas and bloating, come in green capsules and are packaged in counts of 72 and 120. According to Haleon, these products could contain traces of propylene glycol-based coolant, which, if ingested, might lead to unpleasant side effects such as nausea, vomiting, abdominal pain, and diarrhoea.
The 120-count packages were distributed from April 13 to May 5, 2026, and can be identified by their UPC code 300674350419, with an expiry date set for November 30, 2028. The affected lot numbers include TL8K, YH9X, and YH9Y. Meanwhile, the 72-count softgels, identifiable by UPC 300439005721, were released between May 5 and May 14, 2026, with lot number X78N and an expiry date of November 20, 2028.
Consumer Advisory
Haleon has yet to receive any reports of adverse reactions linked to these products; however, they urge consumers to discontinue use immediately. Customers in possession of the recalled items are advised to reach out to Haleon Consumer Relations for guidance on returning the product and obtaining a refund. Contact details are available through Haleon’s official website.
Broader Context of Recalls
This recall of Gas-X Extra Strength Softgels is part of a broader trend, with numerous products facing scrutiny for safety issues in recent months. Notably, Target recently recalled its Up & Up brand baby wipes after routine testing revealed the presence of harmful bacteria. Customers reported various symptoms, prompting an investigation that confirmed the existence of Burkholderia cepacia complex and Burkholderia gladioli—bacteria that can pose serious health risks.
In another incident, Pharmacal recalled a lot of its MG217 Multi-symptom Treatment Cream due to contamination with Staphylococcus aureus, a bacterium known to cause skin infections. Such recalls underscore the importance of stringent quality control measures in the manufacturing process.
Why it Matters
The recall of Gas-X Extra Strength Softgels highlights a growing concern regarding consumer safety in over-the-counter medications. As incidents of contamination emerge, they emphasise the critical need for vigilance in product safety protocols. Consumers must remain informed and proactive about the products they use, as even widely trusted brands can face unexpected challenges. With public health at stake, the importance of transparency and accountability in the pharmaceutical industry cannot be overstated.